F. Monville

688 total citations
5 papers, 534 citations indexed

About

F. Monville is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Molecular Biology. According to data from OpenAlex, F. Monville has authored 5 papers receiving a total of 534 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Oncology, 3 papers in Pulmonary and Respiratory Medicine and 2 papers in Molecular Biology. Recurrent topics in F. Monville's work include Cancer Immunotherapy and Biomarkers (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Cancer Genomics and Diagnostics (2 papers). F. Monville is often cited by papers focused on Cancer Immunotherapy and Biomarkers (3 papers), Lung Cancer Treatments and Mutations (3 papers) and Cancer Genomics and Diagnostics (2 papers). F. Monville collaborates with scholars based in France. F. Monville's co-authors include Daniel Birnbaum, Emmanuelle Charafe‐Jauffret, Luc Xerri, Christophe Ginestier, José Adélaı̈de, François Bertucci, Pascal Finetti, Jocelyne Jacquemier, Nathalie Cervera and A Letessier and has published in prestigious journals such as Oncogene, Annals of Oncology and Immuno-Oncology Technology.

In The Last Decade

F. Monville

5 papers receiving 531 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
F. Monville France 4 344 257 172 56 54 5 534
M. Ángeles Villaronga Spain 17 420 1.2× 139 0.5× 162 0.9× 44 0.8× 40 0.7× 28 577
Hiroki Ueo Japan 13 348 1.0× 173 0.7× 206 1.2× 30 0.5× 38 0.7× 28 501
Robert D. Kendig United States 12 326 0.9× 276 1.1× 91 0.5× 46 0.8× 55 1.0× 15 574
Denis Alférez United Kingdom 12 340 1.0× 300 1.2× 127 0.7× 52 0.9× 40 0.7× 17 551
Fumihiko Kakizaki Japan 9 322 0.9× 215 0.8× 137 0.8× 52 0.9× 35 0.6× 17 517
Ravesanker Ezhilarasan United States 15 400 1.2× 180 0.7× 199 1.2× 30 0.5× 36 0.7× 30 625
Awad Shamma Japan 12 395 1.1× 186 0.7× 151 0.9× 106 1.9× 59 1.1× 16 685
Raquel Batlle Spain 7 345 1.0× 227 0.9× 190 1.1× 28 0.5× 44 0.8× 7 552
Larisa Y. Romanova United States 11 483 1.4× 297 1.2× 230 1.3× 63 1.1× 60 1.1× 13 683
Matti Saarela Finland 6 356 1.0× 112 0.4× 109 0.6× 82 1.5× 49 0.9× 7 497

Countries citing papers authored by F. Monville

Since Specialization
Citations

This map shows the geographic impact of F. Monville's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Monville with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Monville more than expected).

Fields of papers citing papers by F. Monville

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by F. Monville. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Monville. The network helps show where F. Monville may publish in the future.

Co-authorship network of co-authors of F. Monville

This figure shows the co-authorship network connecting the top 25 collaborators of F. Monville. A scholar is included among the top collaborators of F. Monville based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with F. Monville. F. Monville is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

5 of 5 papers shown
1.
2.
3.
Barlési, Fabrice, Laurent Greillier, F. Monville, et al.. (2020). LBA53 Precision immuno-oncology for advanced non-small cell lung cancer (NSCLC) patients (pts) treated with PD1/L1 immune checkpoint inhibitors (ICIs): A first analysis of the PIONeeR study. Annals of Oncology. 31. S1183–S1183. 9 indexed citations
4.
Letessier, A, Sarah Garrido‐Urbani, Christophe Ginestier, et al.. (2006). Correlated break at PARK2/FRA6E and loss of AF-6/Afadin protein expression are associated with poor outcome in breast cancer. Oncogene. 26(2). 298–307. 77 indexed citations
5.
Charafe‐Jauffret, Emmanuelle, Christophe Ginestier, F. Monville, et al.. (2005). Gene expression profiling of breast cell lines identifies potential new basal markers. Oncogene. 25(15). 2273–2284. 444 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. Ángeles Villaronga Breakdown of academic impact, for papers by Hiroki Ueo Breakdown of academic impact, for papers by Robert D. Kendig Breakdown of academic impact, for papers by Denis Alférez Breakdown of academic impact, for papers by Fumihiko Kakizaki Breakdown of academic impact, for papers by Ravesanker Ezhilarasan Breakdown of academic impact, for papers by Awad Shamma Breakdown of academic impact, for papers by Raquel Batlle Breakdown of academic impact, for papers by Larisa Y. Romanova Breakdown of academic impact, for papers by Matti Saarela
Rankless by CCL
2026